Artículo

Bibliometric analysis of the top 100 highly cited articles on sublobectomy for non-small cell lung cancer

Resumen

Objectives The goal of this research is to pinpoint the top 100 most frequently referenced studies on sublobectomy for non-small cell lung cancer. Methods We identified the top 100 most frequently referenced studies on sublobectomy for non-small cell lung cancer by searching the Web of Science database. We extracted key information from the selected studies, including the author, journal, impact factor, type of article, year of publication, country, organization, and keyword. Results To the best of our understanding, this is the inaugural bibliometric study on sublobectomy for non-small cell lung cancer. The publication years of the top 100 most frequently referenced studies span from 1994 to 2022, with citation counts ranging from 51 to 795. The majority of the included studies are original (93/100) and primarily retrospective studies (82/93). The United States leads in terms of published articles and citations, with the Annals of Thoracic Surgery being the most frequently sourced journal (n = 27). High-density keywords primarily originate from limited resection, lobectomy, survival, carcinoma, recurrence, randomized trial, radiotherapy, lung cancer, outcome, 2 cm, as revealed by CiteSpace analysis. Conclusions Our research compiles and analyzes the top 100 most frequently referenced studies in the field of sublobectomy for non-small cell lung cancer. The United States has the most published and cited works on this topic. Currently, the hot keywords for sublobectomy research are gradually shifting towards prognosis and obtaining better evidence-based medical evidence to demonstrate its value in the treatment of non-small cell lung cancer.
Jiang, Wenshuo (59129847200); Zhao, Zhigang (57190214291)
Trends in research on AI-aided drug discovery from 2009 to 2023: A 15-year bibliometric analysis
2025
10.1016/j.ipha.2024.09.001
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85212061111&doi=10.1016%2fj.ipha.2024.09.001&partnerID=40&md5=b3447fcfd17488160d15f721ea76776d
Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Beijing, China
All Open Access; Hybrid Gold Open Access
Scopus
Artículo obtenido de:
Scopus
0 0 votos
Califica el artículo
Subscribirse
Notificación de